Option chain shows key data for Getinge's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Getinge.

Getinge (OTC:GNGBF) Stock, Option Chain

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB

Earnings

Press Releases

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Getinge completes the acquisition of Paragonix Technologies

Small Cap

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

Getinge publishes Annual Report for 2024

Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward

GNGBF

GNGBY

Getinge

Comments

Getinge

Getinge (GNGBF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell